Patent · US Active

Heterocyclic carboxamides as modulators of kinase activity

US10080753B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Bayard R. Huck · Sudbury, US
Xiaoling Chen · Sharon, US
Yufang Xiao · Lexington, US
Ruoxi Lan · Waltham, US
Lizbeth Celeste De Selm · Melrose, US
Constantin Neagu · Belmont, US
Justin Potnick · Acton, US
Srinivasa Karra · Pembroke, US
Theresa L. Johnson · Salem, US

Key dates

Filing date	Aug 3, 2016
Grant date	Sep 25, 2018
Priority date	—
Expiry date	Aug 3, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel heterocyclic carboxamide compounds according to Formula (I) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.